Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/11/2007CA2646714A1 Association products of xanthates and cyclodextrins, and their use
10/11/2007CA2646536A1 Thiazolyl dihydro-indazoles
10/11/2007CA2646515A1 3-unsubstituted n-(aryl- or heteroarvl)-pyrazolori [1,5-a]pyrimidines as kinase inhibitors
10/11/2007CA2646407A1 Novel aminoglycosides and uses thereof in the treatment of genetic disorders
10/11/2007CA2646166A1 3-substituted n-(aryl- or heteroaryl)-pyrazo[1,5-a]pyrimidines as kinase inhibitors
10/11/2007CA2646090A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
10/11/2007CA2646088A1 Novel bi-aryl amines
10/11/2007CA2646086A1 Piperidine derivatives useful for treating osteoarthritis and osteoartrosis
10/11/2007CA2645959A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/11/2007CA2645958A1 Hiv inhibiting 5-amido substituted pyrimidines
10/11/2007CA2645767A1 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
10/11/2007CA2645242A1 Combinations of therapeutic agents for treating cancer
10/11/2007CA2644963A1 Organic compounds
10/11/2007CA2644636A1 Ceramide kinase modulation
10/11/2007CA2644380A1 Benzimidazole derivatives
10/11/2007CA2644143A1 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer
10/11/2007CA2643592A1 A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same
10/11/2007CA2641951A1 Combination of organic compounds
10/11/2007CA2629321A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/11/2007CA2616543A1 Particulate compositions comprising alginate and/or alginic acid
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842855A2 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
10/10/2007EP1842852A1 A cefdinir intermediate
10/10/2007EP1842851A2 Novel compounds
10/10/2007EP1842850A1 Rosiglitazone hydrochloride hemihydrate
10/10/2007EP1842846A1 Phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/10/2007EP1842845A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
10/10/2007EP1842567A2 Intraluminal device with a coating containing a therapeutic agent
10/10/2007EP1842559A1 Particle adjuvant for hifu therapy and the use thereof
10/10/2007EP1842558A1 Composition for inhibiting expression of target gene
10/10/2007EP1842557A1 Drug carrier and drug carrier kit for inhibiting fibrosis
10/10/2007EP1842556A1 Therapeutic agent for attention-deficit hyperactivity disorder
10/10/2007EP1842555A1 Tolerance development inhibitor for narcotic analgesic agent
10/10/2007EP1842550A2 Composition for inducing immunotolerance
10/10/2007EP1842546A1 Cellulose sulfate for the treatment of rhinovirus infection
10/10/2007EP1842545A1 Anti-inflammatory polymer
10/10/2007EP1842544A2 Alginate compositions
10/10/2007EP1842543A1 Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
10/10/2007EP1842542A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
10/10/2007EP1842541A1 Plant components and extracts and uses thereof
10/10/2007EP1842540A1 Sesamin/episesamin compositions
10/10/2007EP1842539A1 Use of N- (dibenz(b,f)oxepin-10-ylmethyl)N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency
10/10/2007EP1842538A2 Treatment for Raynaud's Phenomenon
10/10/2007EP1842537A1 Use of an anti-atherothrombotic compound for the manufacture of medicaments for the treatment of vascular disorders
10/10/2007EP1842536A1 Use of alpha-ketoglutaric acid and 5-hydroxy-methylfurfural for reducing oxidative stress
10/10/2007EP1842535A1 Use of agomelatine to obtain a medication aimed at treating generalised anxiety disorder
10/10/2007EP1842534A1 Metoprolol succinate extended release tablets and methods for their preparation
10/10/2007EP1842533A2 Dosage form that is secured against misuse
10/10/2007EP1842532A2 Oral sparingly water-soluble antifungal formulations and methods of making the same
10/10/2007EP1842527A1 Use of a C-glycoside compound as an agent for activating and regulating skin immunity
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
10/10/2007EP1842425A1 Hygienic and/or cosmetic and/or disinfectant composition containing at least one anti-parasite and/or insect repellent agent
10/10/2007EP1842066A2 Biologically active silver-coated proteins
10/10/2007EP1841868A2 Inhibitor nucleic acids
10/10/2007EP1841792A2 Method for producing albumin conjugates containing gyrase inhibitors
10/10/2007EP1841780A2 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
10/10/2007EP1841776A2 Decladinosyl-macrolides with anti-inflammatory activity
10/10/2007EP1841775A2 Erythromycin derivatives as antibacterial agents
10/10/2007EP1841772A1 Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
10/10/2007EP1841771A2 Diazabenzoýde¨anthracen-3-one compounds and methods for inhibiting parp
10/10/2007EP1841770A2 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/10/2007EP1841769A2 Purine derivatives compositions containing the same and use thereof against cancer
10/10/2007EP1841768A1 Purine derivatives acting as a2a receptor agonists
10/10/2007EP1841767A1 Pyrazolopyridines, their preparation and their medical use
10/10/2007EP1841766A1 Pyrrolopyridines useful in the treatment of inflammation
10/10/2007EP1841765A2 Imidazo[4,5-c]pyridine compound and method of antiviral treatment
10/10/2007EP1841763A1 5-heteroaryl thiazoles and their use as pi3k inhibitors
10/10/2007EP1841762A1 Substituted indoles, compositions containing them, method for the production thereof and their use
10/10/2007EP1841760A2 Pyrimidine derivatives as kinase modulators and method of use
10/10/2007EP1841759A2 5-pyrrolidinylsulfonyl isatin derivatives
10/10/2007EP1841758A1 Substituted triazole derivatives as oxytocin antagonists
10/10/2007EP1841757A2 Heteroaromatic quinoline compounds and their use as pde10 inhibitors
10/10/2007EP1841755A1 Substituted indole ligands for the orl-1 receptor
10/10/2007EP1841754A1 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application
10/10/2007EP1841750A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/10/2007EP1841749A1 Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
10/10/2007EP1841746A1 Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of cns disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates
10/10/2007EP1841744A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
10/10/2007EP1841743A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841742A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
10/10/2007EP1841740A1 3,4,(5)-substituted tetrahvdropyridines
10/10/2007EP1841738A2 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
10/10/2007EP1841737A1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/10/2007EP1841736A1 Indoles useful in the treatment of inflammation
10/10/2007EP1841735A1 Indoles useful in the treatment of inflammation
10/10/2007EP1841734A2 5-aminoindole derivatives
10/10/2007EP1841731A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
10/10/2007EP1841730A1 Cathepsin k inhibitors and atherosclerosis
10/10/2007EP1841728A1 Compounds for treating urinary incontinence
10/10/2007EP1841727A1 Glycine transport inhibitors
10/10/2007EP1841723A1 Decaline derived compounds as pharmaceutically active agents
10/10/2007EP1841466A2 Agents for therapy efficacy monitoring and deep tissue imaging
10/10/2007EP1841465A2 Stilbene derivatives and their use for binding and imaging amyloid plaques
10/10/2007EP1841460A2 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/10/2007EP1841459A2 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain
10/10/2007EP1841449A2 Methods and compositions related to modulating the extracellular stem cell environment
10/10/2007EP1841448A2 Pharmaceutical compositions and methods for restoring beta-cell mass and function
10/10/2007EP1841445A1 Therapeutic nutrient compositions or combinations and methods of their use
10/10/2007EP1841437A2 9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity
1 ... 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 ... 7860